1. Home
  2. BELFB vs AAPG Comparison

BELFB vs AAPG Comparison

Compare BELFB & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

N/A

Current Price

$198.73

Market Cap

2.9B

Sector

N/A

ML Signal

N/A

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$24.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFB
AAPG
Founded
1949
2009
Country
United States
China
Employees
5370
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BELFB
AAPG
Price
$198.73
$24.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$174.25
$48.50
AVG Volume (30 Days)
140.6K
1.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.52
N/A
Revenue Next Year
$7.85
$368.64
P/E Ratio
$42.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$58.00
$17.56
52 Week High
$248.61
$48.45

Technical Indicators

Market Signals
Indicator
BELFB
AAPG
Relative Strength Index (RSI) 40.79 50.60
Support Level $130.49 $23.06
Resistance Level $248.61 $26.01
Average True Range (ATR) 9.39 0.98
MACD -4.99 0.09
Stochastic Oscillator 29.43 77.08

Price Performance

Historical Comparison
BELFB
AAPG

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: